
Prostate Cancer Drugs Global Market Report 2025
Description
Prostate Cancer Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on prostate cancer drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for prostate cancer drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prostate cancer drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Hormone Sensitive Prostate Cancer; Hormone Refractory Prostate Cancer
2) By Therapy: Hormonal Therapy; Chemotherapy; Immunotherapy; Targeted Therapy
3) By End User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Hormone Sensitive Prostate Cancer: Early-Stage Prostate Cancer; Locally Advanced Prostate Cancer; Metastatic Prostate Cancer
2) By Hormone Refractory Prostate Cancer: Castration-Resistant Prostate Cancer (CRPC); Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Companies Mentioned: Astellas Pharma Inc.; AstraZeneca PLC; Johnson & Johnson; Sanofi S.A.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on prostate cancer drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for prostate cancer drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prostate cancer drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Hormone Sensitive Prostate Cancer; Hormone Refractory Prostate Cancer
2) By Therapy: Hormonal Therapy; Chemotherapy; Immunotherapy; Targeted Therapy
3) By End User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Hormone Sensitive Prostate Cancer: Early-Stage Prostate Cancer; Locally Advanced Prostate Cancer; Metastatic Prostate Cancer
2) By Hormone Refractory Prostate Cancer: Castration-Resistant Prostate Cancer (CRPC); Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Companies Mentioned: Astellas Pharma Inc.; AstraZeneca PLC; Johnson & Johnson; Sanofi S.A.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Prostate Cancer Drugs Market Characteristics
- 3. Prostate Cancer Drugs Market Trends And Strategies
- 4. Prostate Cancer Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global Prostate Cancer Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Prostate Cancer Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Prostate Cancer Drugs Market Growth Rate Analysis
- 5.4. Global Prostate Cancer Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Prostate Cancer Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Prostate Cancer Drugs Total Addressable Market (TAM)
- 6. Prostate Cancer Drugs Market Segmentation
- 6.1. Global Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormone Sensitive Prostate Cancer
- Hormone Refractory Prostate Cancer
- 6.2. Global Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hormonal Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- 6.3. Global Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Other End-Users
- 6.4. Global Prostate Cancer Drugs Market, Sub-Segmentation Of Hormone Sensitive Prostate Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Early-Stage Prostate Cancer
- Locally Advanced Prostate Cancer
- Metastatic Prostate Cancer
- 6.5. Global Prostate Cancer Drugs Market, Sub-Segmentation Of Hormone Refractory Prostate Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Castration-Resistant Prostate Cancer (CRPC)
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- 7. Prostate Cancer Drugs Market Regional And Country Analysis
- 7.1. Global Prostate Cancer Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Prostate Cancer Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Prostate Cancer Drugs Market
- 8.1. Asia-Pacific Prostate Cancer Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Prostate Cancer Drugs Market
- 9.1. China Prostate Cancer Drugs Market Overview
- 9.2. China Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Prostate Cancer Drugs Market
- 10.1. India Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Prostate Cancer Drugs Market
- 11.1. Japan Prostate Cancer Drugs Market Overview
- 11.2. Japan Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Prostate Cancer Drugs Market
- 12.1. Australia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Prostate Cancer Drugs Market
- 13.1. Indonesia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Prostate Cancer Drugs Market
- 14.1. South Korea Prostate Cancer Drugs Market Overview
- 14.2. South Korea Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Prostate Cancer Drugs Market
- 15.1. Western Europe Prostate Cancer Drugs Market Overview
- 15.2. Western Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Prostate Cancer Drugs Market
- 16.1. UK Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Prostate Cancer Drugs Market
- 17.1. Germany Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Prostate Cancer Drugs Market
- 18.1. France Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Prostate Cancer Drugs Market
- 19.1. Italy Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Prostate Cancer Drugs Market
- 20.1. Spain Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Prostate Cancer Drugs Market
- 21.1. Eastern Europe Prostate Cancer Drugs Market Overview
- 21.2. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Prostate Cancer Drugs Market
- 22.1. Russia Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Prostate Cancer Drugs Market
- 23.1. North America Prostate Cancer Drugs Market Overview
- 23.2. North America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Prostate Cancer Drugs Market
- 24.1. USA Prostate Cancer Drugs Market Overview
- 24.2. USA Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Prostate Cancer Drugs Market
- 25.1. Canada Prostate Cancer Drugs Market Overview
- 25.2. Canada Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Prostate Cancer Drugs Market
- 26.1. South America Prostate Cancer Drugs Market Overview
- 26.2. South America Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Prostate Cancer Drugs Market
- 27.1. Brazil Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Prostate Cancer Drugs Market
- 28.1. Middle East Prostate Cancer Drugs Market Overview
- 28.2. Middle East Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Prostate Cancer Drugs Market
- 29.1. Africa Prostate Cancer Drugs Market Overview
- 29.2. Africa Prostate Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Prostate Cancer Drugs Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Prostate Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Prostate Cancer Drugs Market Competitive Landscape And Company Profiles
- 30.1. Prostate Cancer Drugs Market Competitive Landscape
- 30.2. Prostate Cancer Drugs Market Company Profiles
- 30.2.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Prostate Cancer Drugs Market Other Major And Innovative Companies
- 31.1. F. Hoffmann-La Roche AG
- 31.2. Abbott Laboratories
- 31.3. Pfizer Inc.
- 31.4. Novartis International AG
- 31.5. F. Hoffmann-La Roche Ltd.
- 31.6. Tolmar Inc.
- 31.7. AbbVie Inc.
- 31.8. Siemens Healthineers AG
- 31.9. Genomic Health Inc.
- 31.10. OPKO Health Inc.
- 31.11. Siemens Healthcare GmbH
- 31.12. MDxHealth SA
- 31.13. Myriad Genetics Inc.
- 31.14. Janssen Biotech Inc.
- 31.15. Clovis Oncology Inc.
- 32. Global Prostate Cancer Drugs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Prostate Cancer Drugs Market
- 34. Recent Developments In The Prostate Cancer Drugs Market
- 35. Prostate Cancer Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Prostate Cancer Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Prostate Cancer Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Prostate Cancer Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.